biosimilars
New Biosimilars Metric Confirms Efficacy Of Adalimumab Switch
Most patients who were switched from adalimumab to an interchangeable biosimilar experienced clinical success, with ...
AUGUST 18, 2025
New Biosimilars Metric Confirms Switching Efficacy
Most patients who were switched from Humira to an interchangeable biosimilar experienced clinical success, with ...
JULY 23, 2025
Most Switches to Adalimumab Biosimilar Yield Clinical Success
Most patients who were switched from Humira to an interchangeable adalimumab biosimilar experienced clinical ...
JUNE 11, 2025
Basics and Benefits of Biosimilars: A Rheumatologist’s Take
Biosimilars can improve patient access and reduce healthcare costs, but understanding basic concepts about this ...
APRIL 27, 2025
Adalimumab Biosimilars: Distinguishing Among the 10
There are several factors that differentiate each of the 10 biosimilars for Humira from one another.
APRIL 25, 2025
Trump Prescription Drug Order Puts Spotlight on Price Tensions for Biosimilars
President Trump issued an executive order aimed at lowering prescription drug prices.
APRIL 24, 2025
Overcoming Biosimilar Utilization Barriers
The successful implementation of an infliximab biosimilar at Boston Medical Center was one of several lessons for ...
APRIL 11, 2025
Follow the Yellow Brick Road for Biosimilars Savings
With 41 biosimilars launched for 11 branded reference products, and at least 10 more expected to enter the market ...
FEBRUARY 18, 2025
Basics and Benefits of Biosimilars: A Rheumatologist’s Take
The use of biosimilars can improve patient access and reduce healthcare costs, but understanding some basic ...
FEBRUARY 13, 2025
Regulatory Reform Needed to Drive Biosimilar Adoption
Biosimilars generated $12.4 billion in savings in 2023, bringing the total savings since their introduction in 2015 ...
DECEMBER 14, 2024
Managing the High Cost of Specialty Medications
Employers and health plans are concerned about managing high-ticket items such as cell and gene therapies, and ...
DECEMBER 14, 2024
Adalimumab Biosimilars: Distinguishing Among the 10
Although all 10 adalimumab biosimilars have garnered FDA approval for every indication granted to Humira, there are ...
DECEMBER 11, 2024
